Hyperbilirubinemia in infants with Gram-negative sepsis does not affect mortality

Early Human Development

Volumn 87, Issue 8, 2011, Pages 515-519

  Van Den Broek, Paul ^a   Verkade, Henkjan J ^a   Hulzebos, Christian V ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN GLUCURONIDE; C REACTIVE PROTEIN; FRESH FROZEN PLASMA; HYDROCORTISONE;

ACINETOBACTER BAUMANNII; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; BLOOD CULTURE; CITROBACTER FREUNDII; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTEROBACTER CLOACAE; ERYTHROCYTE; ESCHERICHIA COLI; FEMALE; GESTATIONAL AGE; GRAM NEGATIVE SEPSIS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; HYPERBILIRUBINEMIA; INFANT; INFANT MORTALITY; INFLAMMATION; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; MALE; MENINGITIS; NECROTIZING ENTEROCOLITIS; PANTOEA; POSITIVE END EXPIRATORY PRESSURE; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SERRATIA MARCESCENS; SURVIVAL;

BACTEREMIA; FEMALE; GESTATIONAL AGE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; RETROSPECTIVE STUDIES;

EID: 79960439933     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.04.003     Document Type: Article

References (29)

1. Stoll B.J., Hansen N.I., Higgins R.D., Fanaroff A.A., Duara S., Goldberg R., et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003. Pediatr Infect Dis J 2005 Jul, 24(7):635-639.
2. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002 Aug, 110(2 Pt 1):285-291.
3. Rinaldi S., Landucci F., De Gaudio A.R. Antioxidant therapy in critically septic patients. Curr Drug Targets 2009 Sep, 10(9):872-880.
4. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N., et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987 Feb 27, 235(4792):1043-1046.
5. Lanone S., Bloc S., Foresti R., Almolki A., Taille C., Callebert J., et al. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 2005 Nov, 19(13):1890-1892.
6. Kadl A., Pontiller J., Exner M., Leitinger N. Single bolus injection of bilirubin improves the clinical outcome in a mouse model of endotoxemia. Shock 2007 Nov, 28(5):582-588.
7. Bernstein J., Brown A.K. Sepsis and jaundice in early infancy. Pediatrics 1962 Jun, 29:873-882.
8. Shamir R., Maayan-Metzger A., Bujanover Y., Ashkenazi S., Dinari G., Sirota L. Liver enzyme abnormalities in Gram-negative bacteremia of premature infants. Pediatr Infect Dis J 2000 Jun, 19(6):495-498.
9. Linder N., Yatsiv I., Tsur M., Matoth I., Mandelberg A., Hoffman B., et al. Unexplained neonatal jaundice as an early diagnostic sign of septicemia in the newborn. J Perinatol 1988, 8(4):325-327.
10. Sturm E., Zimmerman T.L., Crawford A.R., Svetlov S.I., Sundaram P., Ferrara J.L., et al. Endotoxin-stimulated macrophages decrease bile acid uptake in WIF-B cells, a rat hepatoma hybrid cell line. Hepatology 2000 Jan, 31(1):124-130.
11. Moseley R.H. Sepsis and cholestasis. Clin Liver Dis 1999 Aug, 3(3):465-475.
12. Tiker F., Tarcan A., Kilicdag H., Gurakan B. Early onset conjugated hyperbilirubinemia in newborn infants. Indian J Pediatr 2006 May, 73(5):409-412.
13. Quale J.M., Mandel L.J., Bergasa N.V., Straus E.W. Clinical significance and pathogenesis of hyperbilirubinemia associated with Staphylococcus aureus septicemia. Am J Med 1988 Nov, 85(5):615-618.
14. Tiker F., Gulcan H., Kilicdag H., Tarcan A., Gurakan B. Extreme hyperbilirubinemia in newborn infants. Clin Pediatr Phila 2006 Apr, 45(3):257-261.
15. Maisels M.J., Kring E. Risk of sepsis in newborns with severe hyperbilirubinemia. Pediatrics 1992 Nov, 90(5):741-743.
16. Benaron D.A., Bowen F.W. Variation of initial serum bilirubin rise in newborn infants with type of illness. Lancet 1991 Jul 13, 338(8759):78-81.
17. Johnson A.M. Bilirubin in newborn infants. Lancet 1991 Aug 24, 338(8765):512.
18. Johnson A.M. Sepsis and jaundice. Pediatrics 1993 May, 91(5):1018.
19. Roelofsen H., van der Veere C.N., Ottenhoff R., Schoemaker B., Jansen P.L., Oude Elferink R.P. Decreased bilirubin transport in the perfused liver of endotoxemic rats. Gastroenterology 1994 Oct, 107(4):1075-1084.
20. Roelofsen H., Schoemaker B., Bakker C., Ottenhoff R., Jansen P.L., Elferink R.P. Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol 1995 Sep, 269(3 Pt 1):G427-G434.
21. Geier A., Dietrich C.G., Voigt S., Kim S.K., Gerloff T., Kullak-Ublick G.A., et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 2003 Aug, 38(2):345-354.
22. Kim P.K., Chen J., Andrejko K.M., Deutschman C.S. Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. Shock 2000 Aug, 14(2):176-181.
23. Elferink M.G., Olinga P., Draaisma A.L., Merema M.T., Faber K.N., Slooff M.J., et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 2004 Nov, 287(5):G1008-G1016.
24. Ebbesen F., Knudsen A. The risk of bilirubin encephalopathy, as estimated by plasma parameters, in neonates strongly suspected of having sepsis. Acta Paediatr 1993 Jan, 82(1):26-29.
25. Hansen T.W., Maynard E.C., Cashore W.J., Oh W. Endotoxemia and brain bilirubin in the rat. Biol Neonate 1993, 63(3):171-176.
26. Sedlak T.W., Snyder S.H. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 2004 Jun, 113(6):1776-1782.
27. Vitek L. Impact of serum bilirubin on human diseases. Pediatrics 2005 May, 115(5):1411-1412.
28. Wang W.W., Smith D.L., Zucker S.D. Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats. Hepatology 2004 Aug, 40(2):424-433.
29. Hulzebos C.V., van Imhoff D.E., Bos A.F., Ahlfors C.E., Verkade H.J., Dijk P.H. Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants. Arch Dis Child Fetal Neonatal Ed 2008 Sep, 93(5):F384-F388.